The writing of this article, which reports the clinical trial findings of phase one and two of the BIV1-CovIran vaccine, began in June 1400. The article was submitted to BMJ Open on September 30. This magazine is a subset of BMJ Veterans and Weighing Publications.
On January 1, the answers of the judges of the articles were sent by the magazine. The comments of six judges were sent to the authors. The first judge of the article, Dr. Stephen J Thomas of SUNY Upstate Medical University was the lead author of the clinical trial of the BNT162b2 vaccine and the author of the third phase of the vaccine clinical trial article. The authors ‘response to the judges’ comments was sent to the journal on January 7, along with a modified version of the article. On March 28th, the comments of one of the re-judges were sent to the authors. On March 16th, a letter of acceptance of the article was sent by the magazine. The interesting thing about this journal is that the opinions of the judges, the answers of the authors of the article and all the versions of the article will be published in the judging process along with the final version of the article. This article was published on April 19, 1401.